Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AB801 |
Trade Name | |
Synonyms | AB-801|AB 801 |
Drug Descriptions |
AB801 selectively inhibits AXL, which potentially induces immune cell activation and decreases tumor growth (Cancer Res (2023) 83 (7_Supplement): 518). |
DrugClasses | AXL Inhibitor 30 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AB801 | AB801 | 0 | 1 |
AB801 + Docetaxel | AB801 Docetaxel | 0 | 1 |
AB801 + Docetaxel + Zimberelimab | AB801 Docetaxel Zimberelimab | 0 | 1 |